Lupin Limited FII & DII Activity
5-Day Flow Trend
| Date | FII Net (₹ Cr) | DII Net (₹ Cr) |
|---|---|---|
| 2026-04-21 | -1,059.93 | +2,966.89 |
| 2026-04-20 | +683.2 | -4,721.48 |
| 2026-04-18 | +683.2 | -4,721.48 |
Today's Institutional Flow
Foreign Institutional Investors (FII) sold ₹1059.93 Cr in Lupin Limited via cash markets, while Domestic Institutional Investors (DII) showed strong support with net purchases of ₹2966.89 Cr. This marks a clear divergence in sentiment, with local institutions absorbing foreign outflows. Overall, DIIs are stepping in aggressively amid FII bearishness.
Trend vs 5-Day Average
Today’s FII selling contrasts with their own 5-day average purchase of ₹683.2 Cr, indicating a sharp negative shift in short-term positioning. Meanwhile, DII buying reverses their recent 5-day trend of net outflows averaging ₹4721.48 Cr, signaling a potential contrarian rebound.
F&O Positioning Signal
FII derivative activity in Lupin stands flat with ₹0 Cr exposure in F&O, suggesting no immediate hedge or leveraged bet. However, their Index Futures long/short ratio at 1.2 reflects overall market optimism, potentially limiting downside spillover.
Implication for Finance
Strong DII inflows into Lupin may shield the pharma sector from broader FII-driven selloffs tomorrow.
Market-wide FII/DII data — same for all F&O stocks. Date: 2026-04-21